Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02484898 · ClinicalTrials.gov registry record
SEEQ™ Performance Study
A clinical trial of Arrhythmia Type Unknown, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT02484898: Completed study of Arrhythmia Type Unknown, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT02484898 is a study of Arrhythmia Type Unknown that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 200 participants. The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02484898, a study of Arrhythmia Type Unknown, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
Conditions Studied
Study Locations (9)
Florida
- - Clearwater
- - Palm Beach Gardens
- - Sebring
California
- - Larkspur
- - Simi Valley
Colorado
- - Aurora
Georgia
- - Rome
Mississippi
- - Jackson
Nevada
- - Henderson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-08 |
What the finished NCT02484898 record still lists
NCT02484898 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Arrhythmia Type Unknown appearing as the primary indexed condition, and to 0 interventions.
NCT02484898 lists 9 locations in 6 states (Florida, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT02484898 about?
NCT02484898 is a clinical study titled "SEEQ™ Performance Study". The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
What is the current status of trial NCT02484898?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2015-06. Estimated completion is 2016-08.
What conditions does trial NCT02484898 study?
This clinical trial studies the following conditions: Arrhythmia Type Unknown.
Who is sponsoring clinical trial NCT02484898?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02484898 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia